BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11260860)

  • 1. Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma.
    Gimm O; Sutter T; Dralle H
    J Cancer Res Clin Oncol; 2001; 127(3):156-65. PubMed ID: 11260860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medullary carcinoma of the thyroid: diagnosis and therapy].
    Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
    Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of familial medullary thyroid carcinoma].
    Palestini N; Tagliabue M; Cestino L; Farnetti A; Rossetto R; Vendrame A
    Minerva Chir; 2003 Dec; 58(6):801-9. PubMed ID: 14663408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma.
    Raue F; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3582-e3591. PubMed ID: 33974051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
    Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
    Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
    Maia AL; Siqueira DR; Kulcsar MA; Tincani AJ; Mazeto GM; Maciel LM
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):667-700. PubMed ID: 25372577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of hereditary and sporadic medullary thyroid carcinoma.
    Xu L; Zhao YP; Wang WB; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):401-4. PubMed ID: 22954126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medullary thyroid carcinoma in children].
    Berdelou A; Hartl D; Al Ghuzlan A; Mirghani H; Chougnet C; Baudin E; Schlumberger M; Leboulleux S
    Bull Cancer; 2013; 100(7-8):780-8. PubMed ID: 23831771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
    Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
    Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of medullary thyroid cancer.
    Modigliani E; Franc B; Niccoli-sire P
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):631-49. PubMed ID: 11289739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
    Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
    Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
    Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of medullary thyroid carcinoma.
    Massoll N; Mazzaferri EL
    Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma: recent advances and management update.
    Marsh DJ; Learoyd DL; Robinson BG
    Thyroid; 1995 Oct; 5(5):407-24. PubMed ID: 8563482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent subclinical medullary thyroid carcinoma: diagnosis and treatment.
    Henry JF; Denizot A; Puccini M; Gramatica L; Kvachenyuk A; Conte Devolx B; De Micco C
    World J Surg; 1998 Jul; 22(7):752-6; discussion 756-7. PubMed ID: 9606293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.